About Candela
Candela’s brand values of Science, Results, and Trust guide its commitment to clinically proven results to strengthen the longstanding partnerships established with physicians, their practices and the patients they treat.
Established in 1970, Candela is a leading US-based global medical aesthetic device company with headquarters in Marlborough, Massachusetts. The company's technologies enable physicians to provide advanced energy-based solutions for a broad range of medical-aesthetic applications including treatment of benign vascular and pigmented lesions, scar revision, facial resurfacing, wrinkle reduction, acne, spider veins, cellulite reduction, body shaping, gynecological conditions, and tattoo and hair removal.
Candela markets, services and supports its products in nearly 100 countries, with offices in North America, Israel, France, Germany, Italy, Spain, UK, Australia, China, Japan, Hong Kong, and distributors worldwide.
On the July 17th, 2017, Candela announced the successful completion of its acquisition by an affiliate of funds advised by Apax Partners. Apax Partners is a leading global private equity advisory firm.
Candela’s focus is on their customers’ success by building on the strength of Candela’s brands, the technology behind its products, and the high quality of the company’s engineering and product development organization.
Candela supports various charities by using our technologies to help patients with traumatic scarring, vascular defects, birthmarks and other painful or socially debilitating problems.
